Develops genetic medicines for inherited and common conditions.
Jun 2026Revenue $398M/yrExpenses $213M/yr
Reached break-even May 2026
Figures by year
When did MeiraGTx Holdings become profitable?
Its revenue passed its expenses in May 2026. In the 12 months to Jun 2026, revenue was $398M and expenses $213M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $81.4M | $187M | −$106M |
| Dec 2024 | $33.3M | $197M | −$164M |
| Dec 2023 | $14.0M | $151M | −$137M |
| Dec 2022 | $15.9M | $132M | −$116M |
| Dec 2021 | $37.7M | $110M | −$72.8M |
| Dec 2020 | $15.6M | $78.1M | −$62.6M |
| Dec 2019 | $13.3M | $71.6M | −$58.3M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.